Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, follows a specific dosing protocol designed to minimize side effects while maximizing weight loss results. The standard starting dose of 0.25 mg weekly allows your body to adapt to the medication before your prescriber increases the amount. Understanding this titration schedule helps you set realistic expectations for your treatment journey.
Standard Ozempic Starting Dose and Titration Schedule
The FDA-approved starting dose for Ozempic is 0.25 mg injected under the skin once per week. This low initial dose is intentional—it gives your body time to adjust to semaglutide's mechanism of action on your GLP-1 receptors. Most people tolerate this dose well, though some may experience mild nausea during the first week or two.
Your prescriber typically increases your dose every four weeks if you tolerate it well. The standard progression moves from 0.25 mg to 0.5 mg in week four, then to 1.0 mg in week eight, and potentially to 2.4 mg by week twelve. This gradual approach, called titration, reduces gastrointestinal side effects and improves medication adherence compared to starting with higher doses.
The maximum maintenance dose for weight loss treatment is usually 2.4 mg weekly, though some patients respond well at lower doses like 1.0 mg or 1.7 mg. Your individual response depends on factors including your baseline metabolism, kidney function, stomach sensitivity, and genetic predispositions to GLP-1 pathway signaling.
How Semaglutide Starting Doses Affect Weight Loss Outcomes
Clinical trials show that patients starting at 0.25 mg weekly experience measurable appetite suppression within days, with weight loss typically becoming noticeable after 4-8 weeks of consistent dosing. The medication works by slowing stomach emptying and signaling satiety to your brain's hunger centers. At lower starting doses, this effect is modest but builds over time as you titrate upward.
Data from the STEP trials demonstrated that participants reached maximum weight loss effectiveness when their doses increased to 2.4 mg weekly. However, many people achieve their personal weight loss goals at lower maintenance doses, particularly those with genetic variants that enhance GLP-1 receptor sensitivity. PlexusDx's Precision Peptide Genetic Test identifies your inherited response patterns to help your prescriber optimize dosing.
Why Starting Low Prevents Severe Side Effects
Beginning with 0.25 mg instead of jumping to higher doses reduces your risk of severe nausea, vomiting, and stomach discomfort that can derail treatment. Your gastrointestinal system contains millions of GLP-1 receptors, and overwhelming them suddenly can trigger intense side effects. A gradual four-week titration schedule allows your body's chemoreceptors and vagal nerves to acclimate progressively.
Common early side effects like mild nausea typically resolve within a week or two of your first injection. More serious gastrointestinal events are rare at starting doses but increase in frequency if patients jump to high doses prematurely. Your prescriber monitors your tolerance and adjusts the titration speed based on your individual response—some people stay at 0.25 mg for 6-8 weeks if they experience notable side effects.
PlexusDx Personalized Semaglutide and Genetic-Guided Dosing
PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies, serving all 50 states without requiring insurance. Your dose may need to go up—your price won't. PlexusDx charges a flat monthly rate of $149 for semaglutide injections regardless of your current dose level, whether you're at 0.25 mg or 2.4 mg.
The Precision Peptide Genetic Test, available as a $99 add-on after your first month of treatment, analyzes genetic variants in the GLP1R gene (rs6923761), GIPR pathway (rs1800437), FTO metabolism genes (rs9939609), and MC4R signaling (rs17782313). These genetic markers predict how your body will respond to semaglutide titration, helping your PlexusDx prescriber customize your starting dose and escalation timeline. Patients with favorable GLP-1 receptor variants may experience appetite suppression even at lower doses, potentially reducing the need for rapid dose increases.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What if I can't tolerate the standard 0.25 mg starting dose?
Some patients benefit from micro-dosing or extended time at lower doses before escalation. PlexusDx offers a Microdose GLP-1 Protocol at $129/month for those who need slower titration. Your prescriber can also extend the time between dose increases from four weeks to six or eight weeks based on your tolerance.
How long does it take to reach the full 2.4 mg dose?
Following the standard titration schedule, most people reach 2.4 mg within 16 weeks (four months). However, if you experience side effects or prefer a slower approach, your titration can extend to 20-24 weeks or longer. Your starting dose and comfort level determine the actual timeline for reaching maintenance dosing.
Does PlexusDx offer semaglutide at any starting dose level?
Yes, PlexusDx compounded semaglutide injections support any clinically appropriate dose from 0.25 mg up to 2.4 mg weekly. Your prescriber determines the starting dose and titration schedule based on your medical history and goals. The flat $149/month pricing covers your medication at any dose level during your treatment.
Are there safety concerns with starting semaglutide at 0.25 mg?
The 0.25 mg starting dose is well-established and considered safe for most adults without contraindications like personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome. Mild nausea is the most common side effect in the first week, but serious adverse events at starting doses are extremely rare when used as directed.
Can the Precision Peptide Genetic Test change my starting dose?
PlexusDx's Precision Peptide Genetic Test reveals your inherited predisposition to GLP-1 pathway sensitivity. If your genetic profile shows enhanced GLP-1 receptor function, your prescriber may recommend starting at 0.25 mg with slower titration since you may achieve results faster. Conversely, reduced sensitivity variants might support a slightly faster escalation schedule.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic an Injection? Understanding Its Role in Weight Management
How Often to Inject Ozempic for Weight Loss: A Comprehensive Guide